Heightened rates of both cardiovascular (CV) events and subclinical atherosclerosis,
documented by imaging and vascular function techniques are well established in systemic …

Objective Systemic lupus erythematosus (SLE) is associated with increased risk of
cardiovascular disease. Carotid intima media thickness (CIMT) and carotid plaques are both …

Background Patients with systemic lupus erythematosus (SLE) are at increased risk of
atherosclerosis, even after accounting for traditional risk factors. High levels of leptin and low …

Numerous autoimmune-inflammatory rheumatic diseases have been associated with
accelerated atherosclerosis or other types of vasculopathy leading to increased cardio-and …

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease of unknown etiology.
A major cause of morbidity and mortality in SLE is accelerated atherosclerosis. Endothelial …

Cardiovascular disease (CVD) is a major cause of death in systemic lupus erythematosus
(SLE) patients. Although the risk for cardiovascular events in patients with SLE is significant …

Background: Impaired lipid metabolism contributes to accelerated inflammatory responses
in addition to promoting the formation of atherosclerosis in systemic lupus erythematosus …

The purpose of the present study was to determine levels of adipokines and their
relationship with stiffness parameters and disease activity index in SLE patients in …

Renal involvement is a com-mon manifestation in course of systemic lupus erythematous
(SLE) and may occur at any time. In SLE nephritis, the pattern of glomerular injury is …

Neurological involvement is considered to be a serious complication of systemic lupus
erythematosus (SLE). Neuroimaging plays an important role in detecting neurological …